BCM
INBS icon

Bridgeway Capital Management’s Intelligent Bio Solutions INBS Stock Holding History

Bridgeway Capital Management’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21
Closed -$39K – 1357
2022
Q1 		$39K Sell
21
-10
-32% -$23K ﹤0.01% 1299
2021
Q4 		$107K Sell
31
-11
-26% -$50.5K ﹤0.01% 1213
2021
Q3 		$252K Sell
42
-7
-14% -$53.7K ﹤0.01% 1182
2021
Q2 		$465K Buy
49
+41
+513% +$392K 0.01% 1085
2021
Q1 		$102K Buy
+8
New +$138K ﹤0.01% 1329

Other funds holding INBS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bridgeway Capital Management's INBS Position: Q2 2022 in Review

Bridgeway Capital Management sold out of Intelligent Bio Solutions (INBS) in Q2 2022, closing a stake of 21 shares — an estimated $39K sold.

Bridgeway Capital Management first reported a position in INBS in Q1 2021 and held it in 5 quarters. The position peaked at $465K in Q2 2021. 12 funds tracked by Wall St. Rank hold INBS as of Q2 2022.

  • Bridgeway Capital Management reported no remaining Intelligent Bio Solutions position as of Q2 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 21 Intelligent Bio Solutions shares in Q2 2022, an estimated $39K.
  • Bridgeway Capital Management first reported a position in Intelligent Bio Solutions in Q1 2021 and held it in 5 quarters.
  • Bridgeway Capital Management's Intelligent Bio Solutions position peaked at $465K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2022.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.